L. William McIntosh
Amministratore Delegato presso Q-RNA, Inc.
Profilo
L.
William McIntosh is the founder of Treventis Corp.
He is currently the Chief Executive Officer at Q-RNA, Inc. His former positions include President & Chief Executive Officer at Nexell Therapeutics, Inc., Director at VIRxSYS Corp., Oligomerix, Inc., Signature Capital LLC, Medco Containment Services, Inc., Merck & Co., Inc., Zynaxis, Inc., GSK Plc, and VIMRx Pharmaceuticals, Inc. He was also the Chief Operating Officer at Woodbrook Group Holdings, Inc. and President & Chief Operating Officer at FASgen, Inc. McIntosh received his undergraduate degree and MBA from Lehigh University.
Posizioni attive di L. William McIntosh
Società | Posizione | Inizio |
---|---|---|
Q-RNA, Inc.
Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY. | Amministratore Delegato | - |
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Treventis Corp. develops a small molecule drugs for Alzheimer's and other protein misfolding diseases. It developed a proprietary discovery platform, a high-resolution three-dimensional model of the common conformational region, enabling rational design of multiple lead compounds. The company was founded by Christopher J. Barden, Donald F. Weaver and Sultan Darvesh in 2008 and is headquartered in Toronto, Canada. | Fondatore | - |
Precedenti posizioni note di L. William McIntosh
Società | Posizione | Fine |
---|---|---|
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Presidente | 05/04/2010 |
WOODBROOK GROUP HOLDINGS INC. | Direttore operativo | 01/12/2006 |
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Founded in 1997, Signature Capital LLC is a venture capital firm located in Naples, Florida with an additional office in Portland, Maine | Corporate Officer/Principal | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
VIMRx Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Formazione di L. William McIntosh
Lehigh University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
WOODBROOK GROUP HOLDINGS INC. | Finance |
GSK PLC | Health Technology |
MERCK & CO., INC. | Health Technology |
Aziende private | 11 |
---|---|
Nexell Therapeutics, Inc.
Nexell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nexell Therapeutics, Inc. develops, manufactures and markets pharmaceutical therapies. Its cell therapy is used for the treatment of genetic blood disorders, autoimmune diseases, cancer, and regenerative medicine applications. The company is headquartered in Irvine, CA. | Health Technology |
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
Oligomerix, Inc.
Oligomerix, Inc. Drugstore ChainsRetail Trade Oligomerix, Inc. develops novel therapeutics and diagnostic assays for alzheimer diseases. It is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers. The firm's platform is based on small neurotoxic aggregates of proteins such as tau oligomers, an important target for AD and other tauopathies characterized by the progressive accumulation of tau aggregates. The company was founded by James G. Moe, Eliot J. Davidowitz, Ishita Chatterjee and Pedro M. Rojas in 2006 and is headquartered in New York, NY. | Retail Trade |
Q-RNA, Inc.
Q-RNA, Inc. Pharmaceuticals: MajorHealth Technology Q-RNA, Inc. develops drugs for the treatment of Alzheimer's disease. The company was founded on August 30, 2002 and is headquartered in New York, NY. | Health Technology |
FASgen, Inc.
FASgen, Inc. Pharmaceuticals: MajorHealth Technology FASgen, Inc. develops novel molecule therapeutics. It provides therapeutic applications for cancer, infectious diseases, and metabolic disorders including obesity and diabetes. The company was founded by James D. Dick, Frank P. Kuhajda, Albert H. Owens, and Craig A. Townsend in 2000 and is headquartered in Baltimore, MD. | Health Technology |
Medco Containment Services, Inc. | Producer Manufacturing |
Boehringer Mannheim Pharmaceuticals Corp. | |
Zynaxis, Inc.
Zynaxis, Inc. Miscellaneous Commercial ServicesCommercial Services Zynaxis, Inc. develops drug delivery systems. The company is based in Malvern, PA. Zynaxis was acquired by Vaxcel, Inc. on December 06, 1996. | Commercial Services |
VIMRx Pharmaceuticals, Inc. | Health Technology |
Treventis Corp.
Treventis Corp. BiotechnologyHealth Technology Treventis Corp. develops a small molecule drugs for Alzheimer's and other protein misfolding diseases. It developed a proprietary discovery platform, a high-resolution three-dimensional model of the common conformational region, enabling rational design of multiple lead compounds. The company was founded by Christopher J. Barden, Donald F. Weaver and Sultan Darvesh in 2008 and is headquartered in Toronto, Canada. | Health Technology |
Signature Capital LLC
Signature Capital LLC Investment ManagersFinance Founded in 1997, Signature Capital LLC is a venture capital firm located in Naples, Florida with an additional office in Portland, Maine | Finance |
- Borsa valori
- Insiders
- L. William McIntosh